HC, GLP-1R targeting drug (Development Center for Biotechnology)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHC, GLP-1R targeting drug (Development Center for Biotechnology)
Drug Alias NameHC, glucagon-like peptide-1 receptor targeting drug (Development Center For Biotechnology)
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionGlucagon-like peptide 1 receptor modulators
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDevelopment Center for Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDevelopment Center for Biotechnology
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A